Fabuloso Lawsuit & Recall – 2026 Updates on Settlement, Injuries, and Legal Status

BREAKING: Fabuloso Lawsuit Updates

2026 Update: The original Fabuloso class action settlement ($1.93 million) received final court approval on April 25, 2024. The claim filing deadline has passed. The current focus is EPA enforcement against illegally imported Fabuloso products. Handling a Fabuloso mass tort case? See how our Medical Record Review supports your claim

Fabuloso, one of the best-selling multi-purpose cleaners particularly popular in Hispanic communities, has faced significant legal challenges following bacterial contamination allegations that posed serious health risks to consumers. Since February 2023, when Colgate-Palmolive recalled nearly 5 million bottles of Fabuloso due to bacterial contamination, multiple class-action lawsuits have been filed, resulting in a $1.93 million settlement.

This article examines the Fabuloso recall, the bacterial contamination risks, settlement details, and the EPA’s 2024 regulatory actions on illegally imported products. It also covers how medical record review supports attorneys building personal injury claims related to this product safety issue.

What Is Fabuloso and How Is It Commonly Used?

What is Fabuloso?

Fabuloso is a popular multi-purpose cleaner used worldwide for its pleasant fragrance and versatility across multiple surfaces. It has been marketed as an all-purpose cleaner for homes, offices, and other settings for nearly three decades in North America.

Approved Uses

• Surface Cleaning: Fabuloso can be used to wash a number of surfaces including floors and countertops.
• Odor Elimination: Additionally, it is used to remove unpleasant odors from surfaces making them smell pleasant.

Which Fabuloso Products Were Recalled?

Here are the affected Fabuloso Cleaner Products and their UPC codes:

Product Name	Size	UPC Code
Fabuloso Original Multi-Purpose Cleaner, Lavender Scent	22 FL OZ	035000995025
Fabuloso Multi-Purpose Cleaner 2X Concentrated, Lavender Scent	128 FL OZ	035000530585
Fabuloso Multi-Purpose Cleaner, Lavender Scent	210 FL OZ	035000531230
Fabuloso Original Multi-Purpose Cleaner, Refreshing Lemon Scent	22 FL OZ	035000995018
Fabuloso Professional All Purpose Cleaner & Degreaser, Ocean Scent	1 Gallon	035110043739

Fabuloso Multi-Purpose Cleaner in Passion of Fruits and Spring Fresh scents were also included in this recall. For the complete list of UPC and lot codes for all affected products, Find out more on: fabulosorecall.com

Why Was Fabuloso Recalled? Bacterial Contamination Explained

Overview of the Contamination Claims

Colgate-Palmolive recalled nearly 5 million bottles of Fabuloso in February 2023 due to bacterial contamination. The issue arose when certain batches were found to contain Pseudomonas aeruginosa and Pseudomonas fluorescens, bacteria that can cause serious infections.

Why was Fabuloso Contaminated?

• The contamination was identified through routine quality control checks.
• The manufacturer failed to add a necessary preservative to prevent bacterial growth during the manufacturing process.
• Federal safety officials indicated that the products were distributed online and in stores nationwide by several major retailers including Amazon, Dollar General, Family Dollar, The Home Depot, Sam’s Club, Walmart, and others between December 2022 and January 2023.

Health Risks Linked to Contaminated Fabuloso Products

What Are Pseudomonas Bacteria?

The bacteria found in Fabuloso, Pseudomonas aeruginosa, is known to cause respiratory infections, skin infections, and even life-threatening bloodstream infections in people with weakened immune systems. These bacterial strains are particularly dangerous due to their antibiotic resistance and mutating capabilities, making infections difficult to treat.

Who Is at Risk?

• Individuals with compromised immune systems (e.g., cancer patients, transplant recipients)
• People with respiratory conditions like asthma or COPD
• Anyone with open wounds that may come in contact with contaminated surfaces
• People with cystic fibrosis, as Pseudomonas aeruginosa is a predominant cause of lung infections in this population

What Are the Health Risks Associated with the Contaminated Fabuloso Cleaners?

The bacteria found in Fabuloso products can cause serious infections, particularly for people with compromised immune systems. Here are some potential health risks:

1. Respiratory Infections

Inhaling or touching contaminated Fabuloso may cause lung infections, leading to symptoms like:

• Persistent cough
• Shortness of breath
• Chest pain

2. Skin and Eye Irritations

Direct contact with the contaminated cleaner can lead to:

• Rashes
• Redness and swelling
• Eye infections

3. Blood Infections (Sepsis)

In severe cases, Pseudomonas bacteria can enter the bloodstream, causing life-threatening sepsis, which requires immediate medical attention.

4. Urinary Tract Infections (UTIs)

Exposure to Pseudomonas aeruginosa can result in UTIs, particularly in individuals with pre-existing medical conditions. Important: Even if you are healthy, using contaminated Fabuloso on surfaces can spread bacteria to other areas of your home.

Current Status of the Fabuloso Lawsuit (2026)

The Settlement: Finalized and Closed

The $1.93 million Fabuloso class action settlement received final court approval on April 25, 2024. The claim filing deadline (March 13, 2024) has passed, so no new claims can be submitted to this settlement. This fund covered product refunds only not medical expenses or injury-related damages. The settlement resolved claims that consumers:

• Paid premium prices for contaminated products
• Were exposed to harmful bacteria
• Were deceived about the safety of the products

The lead plaintiffs in the consolidated class actions were Elizabeth Dixon, Jeannie Patora, and Arnold Thomas, who alleged that Colgate-Palmolive improperly, deceptively, and misleadingly marketed the products without disclosing the presence of dangerous bacteria.

Separate and Active: Personal Injury Claims

Individuals who developed a bacterial infection linked to contaminated Fabuloso are pursuing individual personal injury lawsuits – a separate legal track from the closed class action settlement above. These claims can seek compensation the class settlement did not cover, including medical expenses, lost wages, and pain and suffering. This is the track most relevant to attorneys evaluating a Fabuloso-related injury claim today.

The Only Open Regulatory Thread: EPA Enforcement on Illegally Imported Product

Separately, in April and August 2024, the EPA and state partners ordered grocery distributors across the Kansas City, Missouri, Kansas, and Nebraska area to stop selling illegally imported Fabuloso disinfectant products containing glutaraldehyde – an ingredient not authorized for U.S. household use. This EPA enforcement action, not the 2023 recall settlement, is the current source of regulatory activity in 2026.

Compensation in the Fabuloso Lawsuit: What Can You Receive?

From the Closed Class Action Settlement:

Eligible consumers could recover a full refund for up to five products (with proof of purchase) or the average retail price for up to two products (without proof). This window has closed – no further refund claims can be filed.

From an Individual Personal Injury Lawsuit (The Active Track):

Plaintiffs who suffered a bacterial infection linked to contaminated Fabuloso may pursue compensation for:

• Medical Expenses: Hospital bills, treatments, medications, and doctor visits
• Lost Wages: Compensation for missing work due to illness
• Pain and Suffering: Emotional and physical distress from the infection
• Legal Fees: Some outcomes include reimbursement for legal costs

Compensation amounts vary based on the severity of health complications and the strength of medical evidence connecting the infection to Fabuloso exposure – which is where organized medical record review becomes essential to building the case.

Recent Updates on the Fabuloso Cleaner Lawsuit

As of 2024, the Fabuloso lawsuit is still progressing. Some recent developments include:

• Colgate-Palmolive has agreed to a $2 million settlement for affected consumers.
• The deadline to file a claim may be closing soon, so it’s essential to act quickly.
• More victims are coming forward, increasing the chances of a higher settlement payout.

How Medical Records Are Used in Fabuloso Injury Claims?

Importance for Attorneys and How Medical Record Review Works

Medical record review services are crucial in the litigation process for Fabuloso lawsuit. These services assist attorneys in several ways:

1. Complete Record Examination: Medical record review services identify contamination through an analysis of the medical histomorphological treatments and outcomes in the patient’s records.
2. Expert Witnesses Facilitation: They assist when lawyers prepare expert witnesses by summarizing specific medical information in a way that is easy to understand.
3. Case Argumentation: Intermediate summaries and their analysis enable the attorneys to strengthen their cases based on factual evidence since they provide a medical evidence and legal interpretation.
4. Data Elements: Physicians compile all medical records in the possession of a healthcare facility.
5. Medical Review Process: Medical records for Fabuloso lawsuit are accessed and reviewed by medical expert for pertinent details concerning the case.
6. Medical Summary Creation: Detailed and comprehensively produced medical summaries relativities have been created for timeframes, incident settings and possible relations injuries to Fabuloso.

Illustrative Examples

The following are illustrative, composite examples of how medical record review supports Fabuloso-related injury claims, and are not citations to actual case law.

Case Study 1: Infection Claim

• Overview: A 50-year-old woman developed a severe infection after using Fabuloso to clean her home. She filed a lawsuit against the manufacturer.
• Challenges: The attorney faced difficulties in proving the direct link between Fabuloso and the infection, as the patient had a complex medical history.
• Solutions: The attorney engaged a medical record review services to analyze the patient’s medical history and treatment records. The review identified patterns and timelines that supported the claim, demonstrating that the onset of the infection coincided with the use of Fabuloso.

Case Study 2: Respiratory Issues Allegation

• Overview: A 65-year-old male blamed the respiratory problems he developed at home on the use of Fabuloso at his residence and subsequently sought help from a Product Liability case.
• Challenges: The lawyer’s work required a lot of effort as he had to deal with numerous respiratory issues and vasculitis evidence related to the use of Fabuloso.
• Solutions: Using a medical record review service, the lawyer managed to gather a detailed account of the patient’s medical history, treatment, and events leading up to the respiratory diagnosis. This account eased the preparation of the expert witnesses on the risks involved in using Fabuloso that were likely to be raised during litigation.

Conclusion

The Fabuloso lawsuit and its $1.93 million consumer settlement represent a significant case in consumer product mass tort litigation. The 2023 recall and subsequent settlement highlight the importance of proper manufacturing processes and quality control in household cleaning products.

The original class action settlement has closed, with refunds distributed to eligible claimants. Individuals who suffered bacterial infections continue to pursue separate personal injury claims, and the EPA’s enforcement actions against illegally imported Fabuloso products remain the primary source of ongoing regulatory attention in 2026.

For attorneys handling Fabuloso-related personal injury claims, medical record review services continue to play a crucial role in documenting and establishing the connection between exposure and health issues.

Frequently Asked Questions

Does the current Fabuloso Product line still carry litigation risk for new claims?

Standard Fabuloso products sold today are not part of the 2023 recall and are not, on their own, a basis for a new claim. The live litigation risk is narrower:

• Any client exposure tied specifically to the recalled lot codes (Dec 14, 2022 – Jan 23, 2023)
• exposure to illegally imported Fabuloso disinfectant products flagged in the EPA’s 2024 enforcement actions, which is a separate and unrelated product line.
• Confirming which category a client’s product falls into is the first step in evaluating whether a claim exists.

How can attorneys verify whether a client’s product falls within the recall scope?

Cross-check the product’s UPC code and manufacturing lot code against the official recall list at fabulosorecall.com – the lot code is printed on the back of the bottle, above the label. Affected lot codes begin with 2348US78 through 2365US78 or 3001US78 through 3023US78. If a client no longer has the physical bottle, purchase records, photos, or retailer receipts can help establish the product and timeframe, which medical record review can then be cross-referenced against for timeline consistency.

Is the Product Refund Relevant to a Personal Injury Case?

No — and this is a distinction worth clarifying with clients early. The $1.93 million class action settlement covered product cost only (a refund or replacement value), not medical expenses, lost wages, or pain and suffering. A client who already received a class action refund has not resolved a separate personal injury claim, and the refund does not offset or affect the value of an individual injury lawsuit. The two are legally and financially independent.

What must an attorney establish to bring an individual personal injury claim for a Fabuloso-related infection?

Four elements typically need to be documented:

• The client used a product matching a recalled lot code within the affected manufacturing window
• A diagnosed infection consistent with Pseudomonas aeruginosa or P. fluorescens exposure
• A treatment timeline that plausibly connects product use to symptom onset
• Medical records ruling out more likely alternative causes

Organized medical chronology work is typically the deciding factor in whether causation holds up, since it’s what ties the exposure timeline to the clinical record in a way that withstands scrutiny.

What bacteria were found in Fabuloso?

The recall was due to Pseudomonas aeruginosa and Pseudomonas fluorescens, both of which can cause infections in humans.

Are all Fabuloso products affected by the recall?

No, only certain batches and sizes were contaminated. Check the recall list for details.

What are the latest EPA actions regarding Fabuloso products?

In 2024, the EPA ordered multiple grocery stores and distributors across Kansas City, Missouri, Kansas, and Nebraska to stop selling illegally imported Fabuloso disinfectant products containing glutaraldehyde, an unauthorized ingredient that poses health risks to consumers.